BBC NEWS Americas Africa Europe Middle East South Asia Asia Pacific Arabic Spanish Russian Chinese Welsh
BBCi CATEGORIES   TV   RADIO   COMMUNICATE   WHERE I LIVE   INDEX    SEARCH 

BBC NEWS
 You are in: Health
Front Page 
World 
UK 
UK Politics 
Business 
Sci/Tech 
Health 
Background Briefings 
Medical notes 
Education 
Entertainment 
Talking Point 
In Depth 
AudioVideo 


Commonwealth Games 2002

BBC Sport

BBC Weather

SERVICES 
Wednesday, 22 August, 2001, 23:55 GMT 00:55 UK
Gene fingerprint could spot cancer
cancer cells
Prostate cancer cells under the microscope
Scientists may be one step closer to gaining the ability to "fingerprint" prostate cancers - spotting which are the most likely to spread.

If it works, the technique could help spare thousands of older men the risks involved with surgery.

The prostate gland is found near the bladder in men, and its cancer is the second most common male cancer in the UK.

Doctors who discover evidence of prostate cancer face a dilemma, as there is a real risk that intervening could cause more harm than it prevents.

Many prostate cancers are relatively benign and slow-growing, meaning that, particularly in elderly men, they may have no impact on life expectancy.

Risky operation

Surgery to tackle prostate cancer carries a significant risk of incontinence, impotence, or both, as the gland lies close to nerves important to urination and sexual function.

However, others are aggressive and fast-growing, so doctors have to take action with either surgery or radiotherapy.


This approach could give us many new diagnostic tests within three to five years

Professor Mark Rubin, University of Michigan
Often, an uncertain tactic of "watchful waiting" is employed, with frequent checks to see if the cancer is growing fast, but this can be disconcerting for patients who have been told they have cancer but are receiving no treatment.

The latest research, published in the journal Nature on Thursday, looked at prostate samples from 50 men.

Malignant tumours had large numbers of genes which varied from normal prostate tissue, they found.

Researchers then compared tissue from localised, non-spreading prostate tumours, and tissue from aggressive, spreading cancers.

They found two new genes which appear to have a role in the development of the cancer - higher levels of gene expression in the tissue were associated with a worse prognosis for the patient.

Spotting the difference

Professor Mark Rubin, from the University of Michigan Medical School, said: "The ultimate goal is to help physicians determine which patients need to immediate, aggressive treatment and which can be watched and treated conservatively.

"This approach could give us many new diagnostic tests within three to five years.

"Eventually, it could lead to a diagnostic kit physicians could use to determine the best treatment and prognosis for their patients with prostate cancer."


Molecular profiles give much more specific information on the stage of a tumour than can be gained using conventional diagnostic techniques

Cancer Research Campaign spokesman
Although prostate cancer, in which doctors face a choice between radically different treatment strategies, is an obvious choice for "tailored treatments", other researchers are hopeful that the genetic makeup either of the individual, or, more particularly, of the tumour, will be key to treatment choice in various cancers.

A spokesman for the Cancer Research Campaign said: "Molecular signatures have the power to reveal exactly which genes are switched on and which are switched off in a cancer.

"We already know about some of the key cancer genes. Molecular profiling is throwing up new genes and understanding their function is the next step.

"The short term benefits locked up in genetic signatures lie in diagnosis - molecular profiles give much more specific information on the stage of a tumour than can be gained using conventional diagnostic techniques.

"And this means doctors can better tailor treatment to individual patients. In the long term, genetic signatures are also throwing up new leads for anticancer drug design."

See also:

17 Mar 00 | C-D
Prostate cancer
09 Aug 01 | Health
Robotic prostate surgery launched
Internet links:


The BBC is not responsible for the content of external internet sites

Links to more Health stories are at the foot of the page.


E-mail this story to a friend

Links to more Health stories